Partner, Nixon Peabody LLP
Co-Founder, Fate Therapeutics
Managing Director, Redstar Ventures
Founder, Avalon Ventures
Founder and Managing Partner, Frazier Healthcare Ventures
Dir., Hillblom Center for the Biology of Aging, UC San Francisco
Director, Neurobiotics Laboratory, University of Washington
President and CEO, Hudson-Webber Foundation
|
|
| Entry | Author | Date | Location | |
|---|---|---|---|---|
| Kala Funnels $6.2M Into New Drugs for Eye and Lung Diseases | Arlene Weintraub | 03/19/12 | Boston | |
| Regeneron Debuts Eye Drug, as Rivals Race to Grab Share of Hot Market | Arlene Weintraub | 12/01/11 | New York | |
| Ocular Therapeutix Adds $6M to C Round | Ryan McBride | 01/12/11 | Boston | |
| RXi, EyeGate Team Up | Gregory T. Huang | 09/22/10 | Boston | |
| Optherion Sells $5M in Convertible Notes and Warrants | Ryan McBride | 09/17/09 | Boston | |
| Dyax and Fovea Strike Drug Pact | Ryan McBride | 02/10/09 | Boston | |
| Page 1 of 1 | ||||